UNSPSC 51201616: Poliovirus vaccine

This classification denotes a vaccine for a species of enterovirus which is the causal agent of poliomyelitis in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection.

UNSPSC 51201616 Poliovirus vaccine is a Commodity code that covers immunizations against polio and related viral diseases procured by state health departments and similar public health authorities. The code encompasses the acquisition of licensed vaccines for disease prevention and public health campaigns, typically in multi-dose formulations supplied by established pharmaceutical manufacturers. State and local health departments are the primary issuing bodies under this code, purchasing vaccines for routine immunization programs, outbreak response, and stockpiling to meet population-wide immunization requirements.

Recent activity under the code is sparse. The Mississippi State Department of Health posted a sole source notice in July 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026 — though this notice addresses yellow fever vaccine rather than polio vaccine itself, indicating potential misclassification or scope overlap in state procurement systems. The notice contained no quantity, contract term, or estimated dollar value. Geographic activity is limited to Mississippi based on available records; broader state or regional procurement patterns under this code are not evident from current solicitations.